Atopic Patients Show Increased Interleukin 4 Plasma Levels but the Degree of Elevation Is Not Sufficient to Upregulate Interleukin-4-Sensitive Genes
Sign Up to like & getrecommendations! Published in 2019 at "Skin Pharmacology and Physiology"
DOI: 10.1159/000499431
Abstract: Background: Atopic diseases constitute a major health challenge for industrialized countries, and elevated levels of interleukin 4 (IL-4) frequently characterize these disorders. Previous in vitroanalyses have indicated that IL-4 strongly upregulates the expression of IL-4-sensitive… read more here.
Keywords: atopic patients; sensitive genes; expression; degree elevation ... See more keywords
Risk of Adverse Events of Live-Attenuated COVID-19 Vaccination Among Atopic Patients
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Asthma and Allergy"
DOI: 10.2147/jaa.s386611
Abstract: Purpose Atopic patients have more risk of adverse drug reactions. COVID-19 vaccination is very important in the current situation. We still do not have data about risks of adverse effects from vaccine in atopic patients.… read more here.
Keywords: live attenuated; covid vaccination; atopic patients; risk adverse ... See more keywords
Chronic Pruritus in Atopic Patients Treated with Dupilumab: Real Life Response and Related Parameters in 354 Patients
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph15070883
Abstract: Chronic pruritus is a major symptom of atopic dermatitis (AD). Its etiopathogenesis is complex, and an understanding of the driving factors of its pathogenesis allows for the development of new molecule-targeted therapies. Dupilumab, targeting and… read more here.
Keywords: chronic pruritus; life; pruritus; atopic patients ... See more keywords